Description of the population | |
Cohort | 309 |
Age (years) | 63 ± 13 |
Male gender | 210 (68,0) |
BMI (Kg/m2) | 26.2 ± 6.1 |
NYHA class I II III IV | 50 (16.6) 121 (40.2) 130 (43.2) 0 (0.0) |
EuroSCORE II (%) | 1.12 [0.74–1.99] |
Risk factors | |
Previous cardiac surgery | 4 (1.3) |
Hypertension | 169 (56.1) |
Diabetes | 27 (9.0) |
Dyslipidemia | 73 (24.3) |
COPD | 28 (10.1) |
Previous stroke | 0 (0.0) |
PVD | 6 (2.2) |
AF | 83 (27.4) |
Pacemaker-ICD | 10 (3.3) |
CKD | 32 (10.6) |
Echocardiographic features | |
LVEF (%) | 56.8 ± 6.1 |
PAP (mmHg) | 34.4 ± 9.4 |
MV etiology Degenerative Secondary Endocarditis Other | 260 (84.1) 42 (13.6) 2 (0.6) 5 (1.6) |
MV anulus (mm) | 42 ± 4 |
MV prolapse PML AML Bileaflet | 242 (78.3) 48 (15.5) 32 (10.4) |
TR 0 1+ 2+ 3+ 4+ | 18 (7.4) 162 (66.4) 26 (10.7) 31 (12.7) 7 (2.9) |